Breaking News, Promotions & Moves

Newleos Therapeutics Appoints Timothy Noyes as President & CEO

Noyes brings to Newleos 30+ years of experience and a track record of leading biopharma companies through critical phases of innovation and growth.

Author Image

By: Charlie Sternberg

Associate Editor

Timothy Noyes.

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing treatments for neuropsychiatric disorders, has appointed Timothy Noyes as President and Chief Executive Officer. Noyes succeeds David Donabedian, Ph.D., Founding President and CEO of Newleos and Executive Partner at Longwood Fund, who will continue to serve the company in an advisory capacity. Experience Noyes brings to Newleos more than 30 years of experience and a track record of leading biopharmaceutical co...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters